GW Henssler & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.1M Sell
179,384
-1,663
-0.9% -$195K 1.03% 32
2026
Q1
$21.8M Sell
181,047
-6,443
-3% -$744K 1.03% 35
2025
Q4
$19.7M Sell
187,490
-2,268
-1% -$213K 0.95% 39
2025
Q3
$15.9M Buy
189,758
+10,637
+6% +$876K 0.8% 53
2025
Q2
$14.2M Buy
179,121
+6,926
+4% +$551K 0.76% 56
2025
Q1
$15.5M Buy
172,195
+9,020
+6% +$842K 0.89% 50
2024
Q4
$18.5M Sell
163,175
-1,944
-1% -$200K 1.06% 42
2024
Q3
$18.8M Buy
165,119
+1,183
+0.7% +$141K 1.06% 42
2024
Q2
$20.3M Sell
163,936
-6,421
-4% -$827K 1.22% 37
2024
Q1
$22.5M Sell
170,357
-2,986
-2% -$368K 1.32% 31
2023
Q4
$18.9M Sell
173,343
-4,404
-2% -$457K 1.25% 35
2023
Q3
$18.3M Sell
177,747
-2,337
-1% -$252K 1.25% 34
2023
Q2
$20.8M Sell
180,084
-1,992
-1% -$226K 1.36% 33
2023
Q1
$19.4M Sell
182,076
-4,976
-3% -$537K 1.29% 34
2022
Q4
$20.8M Sell
187,052
-1,879
-1% -$192K 1.46% 24
2022
Q3
$16.3M Sell
188,931
-650
-0.3% -$58K 1.22% 33
2022
Q2
$17.3M Buy
189,581
+123
+0.1% +$10.9K 1.28% 32
2022
Q1
$15.5M Buy
189,458
+5,703
+3% +$450K 0.94% 45
2021
Q4
$14.1M Sell
183,755
-1,724
-0.9% -$137K 0.9% 45
2021
Q3
$13.9M Sell
185,479
-14,486
-7% -$1.1M 0.97% 47
2021
Q2
$15.6M Buy
+199,965
New +$14.9M 1.02% 44
2014
Q2
Sell
-4,685
Closed -$254K 156
2014
Q1
$254K Buy
4,685
+187
+4% +$9.68K 0.03% 142
2013
Q4
$214K Sell
4,498
-367
-8% -$16.8K 0.03% 154
2013
Q3
$221K Sell
4,865
-314
-6% -$14.3K 0.03% 141
2013
Q2
$229K Buy
+5,179
New +$231K 0.03% 132

Other funds holding MRK

GW Henssler & Associates's MRK Position: Q2 2026 in Review

GW Henssler & Associates reduced its Merck (MRK) stake by 0.92% in Q2 2026, selling an estimated $195K and leaving 179,384 shares worth $23.1M. The position accounts for 1.03% of the portfolio, ranked #32.

GW Henssler & Associates first reported a position in MRK in Q2 2013 and has held it in 25 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • GW Henssler & Associates held 179,384 shares of Merck worth $23.1M as of Q2 2026.
  • GW Henssler & Associates sold 1,663 Merck shares in Q2 2026, an estimated $195K.
  • Merck made up 1.03% of GW Henssler & Associates's portfolio in Q2 2026, its #32 holding.
  • GW Henssler & Associates first reported a position in Merck in Q2 2013 and has held it in 25 quarters since.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on GW Henssler & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.